IRadimed Corporation

IRMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$82.46

+$0.34 (+0.41%)

At close: Sep 21, 2026, 4:00 PM ET

$82.21

-$0.25 (-0.30%)

Pre-market: Sep 22, 2026, 8:48 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $1.05B

Enterprise Value $995.01M

Beta 0.90

Average Volume 132.63K

Shares Outstanding (Diluted) 12.87M

Shares Change YoY 0.32%

Institutional Ownership 59.68%

Exchange NASDAQ

ISIN US46266A1097

Price Performance

Price Change 1M -6.4%

Price Change 3M -10.7%

Price Change 6M -19.0%

Price Change YTD -13.7%

Price Change 1Y 16.6%

Price Change 3Y 89.7%

Price Change 5Y 141.2%

1M CAGR (ann.) -10.6%

1Y CAGR (ann.) 15.5%

5Y CAGR (ann.) 21.2%

All-Time CAGR 19.9%

Valuation

PE Ratio 46.07

Forward PE 34.06

PEG Ratio 3.89

Forward PEG 2.96

PS Ratio 12.21

Forward PS 10.40

PB Ratio 10.36

P/FCF Ratio 42.28

P/Adj. FCF Ratio 46.35

P/OCF Ratio 38.90

EV/Sales 11.52

EV/EBIT 43.53

EV/EBITDA 32.41

EV/FCF 39.91

Earnings Yield 2.2%

FCF Yield 2.4%

Adj. FCF Yield 2.2%

Financial Health

Net Cash $59.08M

Total Debt $0

Cash & Short-Term Investments $59.08M

Total Assets $114.98M

Current Ratio 9.46

Quick Ratio 8.13

Debt / Equity Ratio 0.00

Debt / EBITDA 0.00

Debt / FCF 0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 50.89

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 75.9%

Operating Profit Margin 31.9%

EBITDA Margin 36.0%

Net Profit Margin 26.7%

FCF Margin 28.9%

Adj. FCF Margin 26.3%

SBC / Revenue 2.5%

SBC Impact (per share) -8.8%

Returns

Return on Assets 20.1%

Return on Equity 23.4%

Return on Invested Capital 20.2%

Return on Capital Employed 26.0%

Return on Tangible Assets 20.7%

Historical Growth (CAGR)

Revenue CAGR 3Y 13.0%

Revenue CAGR 5Y 19.6%

Revenue CAGR 10Y 9.2%

EPS CAGR 3Y 15.6%

EPS CAGR 5Y 37.1%

EPS CAGR 10Y 9.5%

FCF CAGR 3Y 51.5%

FCF CAGR 5Y 26.2%

FCF CAGR 10Y 12.8%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y 18.9%

Revenue Growth Next 3Y 15.2%

Earnings Date Nov 1, 2026

EPS Estimate (next Q) $0.52

EPS Growth Est (next Q) 10.6%

Revenue Est (next Q) $23.2M

Revenue Growth Est (next Q) 9.4%

Fair Value Estimates

Graham Number $17.90

Graham Upside -78.3%

Lynch Fair Value $44.75

Lynch Upside -45.7%

Price Target $100

Price Target Upside 21.3%

Cash Flow

Operating Cash Flow $27.14M

Free Cash Flow $24.93M

Adj. Free Cash Flow $22.74M

FCF Per Share $1.95

OCF Per Share $2.12

OCF/S Ratio 31.4%

Income Statement

Revenue $86.34M

Gross Profit $65.5M

Operating Income $27.55M

EBITDA $30.7M

Net Income $23.05M

EPS (Diluted) $1.79

Revenue / Employee $520.11K

Profit / Employee $138.88K

Employees 166

Dividends

Annual Dividend $1.10

Dividend Yield 1.33%

Payout Ratio 61.5%

FCF Payout Ratio 63.5%

Adj. FCF Payout Ratio 69.6%

Dividend Growth (YoY) 61.8%

Pay Frequency Quarterly

Ex-Dividend Date Aug 13, 2026